⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 18, 2020Science Translational MedicineOpen Access

Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure

View Full Paper

Ask AI

Bookmark

Share

Abstract

-acetyl cysteine for late-presenting patients. Synthetic HS provides a potential approach for the treatment of APAP-induced ALF.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Arnold et al. (2020) studied this question.

synapsesocial.com/papers/6a815070dd9b32ddc29cd2c1 https://doi.org/10.1126/scitranslmed.aav8075

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune responseOriginal Research · 2004 · 463 citations
2Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsisIn Vitro Study · 2013 · 298 citations
3Cell Surface Heparan Sulfate Proteoglycans: Selective Regulators of Ligand-Receptor EncountersReview · 2000 · 363 citations
4Mechanistic Biomarkers Provide Early and Sensitive Detection of Acetaminophen-Induced Acute Liver Injury at First Presentation to HospitalDiagnostic Study · 2013 · 429 citations